Patients with melanoma treated with immune checkpoint inhibitors who had non-thyroid endocrine and skin immune-related adverse events have better prognosis: A systematic review and meta-analysis

BACKGROUND: Several studies have reported an association between the occurrence of immune-related adverse events (irAEs) and prognosis in patients with melanoma treated with immune checkpoint inhibitors (ICIs), but the results remain controversial. We conducted a systematic review and meta-analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Qian, Sun, Hongyan, Wu, Nan, Hu, Yue, Zhang, Fangqing, Cong, Xianling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515964/
https://www.ncbi.nlm.nih.gov/pubmed/36185176
http://dx.doi.org/10.3389/fonc.2022.976224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515964/
https://www.ncbi.nlm.nih.gov/pubmed/36185176
http://dx.doi.org/10.3389/fonc.2022.976224

Ejemplares similares